AAAAAA

   
Results: 1-12 |
Results: 12

Authors: BULPITT CJ FLETCHER AE DOSSEGGER L NEISS A NIELSEN T VIERGUTZ S
Citation: Cj. Bulpitt et al., QUALITY-OF-LIFE IN CHRONIC HEART-FAILURE - CILAZAPRIL AND CAPTOPRIL VERSUS PLACEBO, HEART, 79(6), 1998, pp. 593-598

Authors: ZANCHETTI A BOND MG HENNIG M NEISS A MANCIA G DALPALU C HANSSON L MAGNANI B RAHN KH REID J RODICIO J SAFAR M ECKES L RAVINETTO R
Citation: A. Zanchetti et al., RISK-FACTORS ASSOCIATED WITH ALTERATIONS IN CAROTID-INTIMA-MEDIA THICKNESS IN HYPERTENSION - BASE-LINE DATA FROM THE EUROPEAN LACIDIPINE STUDY ON ATHEROSCLEROSIS, Journal of hypertension, 16(7), 1998, pp. 949-961

Authors: KLEEMANN A ECKERT S VONECKARDSTEIN A LEPPER W SCHERNIKAU U GLEICHMANN U HANRATH P FLECK E NEISS A ASSMANN G BREITHARDT G
Citation: A. Kleemann et al., EFFECTS OF LOVASTATIN ON RESTENOSIS AFTER PTCA AND ON PROGRESSION OF CORONARY-ARTERY DISEASE - THE CHOLESTEROL-LOWERING ATHEROSCLEROSIS PTCA TRIAL (CLAPT), Journal of the American College of Cardiology, 29(2), 1997, pp. 3874-3874

Authors: BESTEHORN HP RENSING UFE ROSKAMM H BETZ P BENESCH L SCHEMEITAT K BLUMCHEN G CLAUS J MATHES P KAPPENBERGER L WIELAND H NEISS A
Citation: Hp. Bestehorn et al., THE EFFECT OF SIMVASTATIN ON PROGRESSION OF CORONARY-ARTERY DISEASE -THE MULTICENTER CORONARY INTERVENTION STUDY (CIS), European heart journal, 18(2), 1997, pp. 226-234

Authors: KLEEMANN A ECKERT S VONECKARDSTEIN A LEPPER W SCHERNIKAU U GLEICHMANN U HANRATH P FLECK E NEISS A ASSMANN G BREITHARDT G
Citation: A. Kleemann et al., EFFECTS OF LOVASTATIN ON PROGRESSION OF CORONARY-ARTERY DISEASE AND RESTENOSIS AFTER PTCA - THE CHOLESTEROL-LOWERING ATHEROSCLEROSIS PTCA TRIAL (CLAPT), Atherosclerosis, 134(1-2), 1997, pp. 265-265

Authors: SCHMITT HJ VONKONIG CHW NEISS A BOGAERTS H BOCK HL SCHULTEWISSERMANN H GAHR M SCHULT R FOLKENS JU RAUH W CLEMENS R
Citation: Hj. Schmitt et al., EFFICACY OF ACELLULAR PERTUSSIS-VACCINE IN EARLY-CHILDHOOD AFTER HOUSEHOLD EXPOSURE, JAMA, the journal of the American Medical Association, 275(1), 1996, pp. 37-41

Authors: SCHMITT HJ SCHUIND A KNUF M ZEPP F BEUTEL K VONKONIG CHW NEISS A BOCK HL BOGAERTS H CLEMENS R
Citation: Hj. Schmitt et al., ACELLULAR PERTUSSIS VACCINES - THE RATIONALE FOR AN EFFICACY TRIAL INGERMANY, The Journal of infectious diseases, 174, 1996, pp. 287-290

Authors: ROSENTHAL J BAHRMANN H BENKERT K BAUMGART P BONNER G KLEIN G NEISS A SCHNELLE K FROHLICH ED
Citation: J. Rosenthal et al., ANALYSIS OF ADVERSE-EFFECTS AMONG PATIENTS WITH ESSENTIAL-HYPERTENSION RECEIVING AN ACE-INHIBITOR OR A BETA-BLOCKER, Cardiology, 87(5), 1996, pp. 409-414

Authors: MESSERER D NEISS A HOROWITZ MM HOELZER D GALE RP
Citation: D. Messerer et al., COMPARISON OF CHEMOTHERAPY AND BONE-MARROW TRANSPLANTS USING 2 INDEPENDENT CLINICAL DATABASES, Journal of clinical epidemiology, 47(10), 1994, pp. 1119-1126

Authors: SCHMITT HJ JUST M NEISS A
Citation: Hj. Schmitt et al., WITHDRAWAL OF A MUMPS VACCINE - REPLY, European journal of pediatrics, 153(6), 1994, pp. 467-468

Authors: BOND G DALPALU C HANSSON L MAGNANI B MANCIA G NEISS A RAHN KH REID JL RODICIO JL SAFAR M ZANCHETTI A
Citation: G. Bond et al., THE ELSA TRIAL - PROTOCOL OF A RANDOMIZED TRIAL TO EXPLORE THE DIFFERENTIAL EFFECT OF ANTIHYPERTENSIVE DRUGS ON ATHEROSCLEROSIS IN HYPERTENSION, Journal of cardiovascular pharmacology, 23, 1994, pp. 85-87

Authors: SCHMITT HJ JUST M NEISS A
Citation: Hj. Schmitt et al., WITHDRAWAL OF A MUMPS VACCINE - REASONS AND IMPACTS, European journal of pediatrics, 152(5), 1993, pp. 387-388
Risultati: 1-12 |